Infliximab Concentration and Infliximab Antibody
Desired Epic Build
* = editable field
| Cerner Primary Mnemonic: | Infliximab Concentration & Ab | |||||||||
| PDM | 5963016 | |||||||||
| Informatics - Workgroup | Tox/TDM | |||||||||
| Synonyms * | Remicade Anti-TNF-alpha | |||||||||
| Display Name * | Infliximab Concentration and Infliximab Antibody | |||||||||
| Specimen Sources (combined Order Entry and Specimen Navigator) * | ||||||||||
| Specimen Types (combined Order Entry and Specimen Navigator) * |
Blood
|
|||||||||
| Body Fluids (types sent through AOEs) | ||||||||||
| Specimen Navigator Specimen Types | ||||||||||
| Specimen Navigator Specimen Sources | ||||||||||
| Specimen Navigator Short Name | ||||||||||
| Ordering info (EPIC SmartText) | Provides infliximab drug concentration levels as well as levels of anti-infliximab antibodies. In the absence of anti-infliximab antibodies, the infliximab drug level typically reflects the total infliximab concentration in serum. In the presence of anti-infliximab antibodies, the infliximab drug level typically reflects the antibody-unbound fraction of infliximab concentration in serum. The presence of infliximab drug, even at concentrations well above target treatment levels (>50 μg/mL), does not interfere with the anti-infliximab antibody detection. This assay may be helpful for any patients on infliximab therapy for diseases such as Crohn's disease, inflammatory bowel disease, ulcerative colitis, rhematoid arthritis, or other autoimmune conditions. | |||||||||
| IP Orderable (inpatient) | Yes | |||||||||
| OP Orderable (outpatient) | Yes | |||||||||
| AOEs * | ||||||||||
| AP AOEs | ||||||||||
| Special History | No | |||||||||
| Build Comments | ||||||||||
| Filter * | ||||||||||
| Cerner Site Restrict | LabCorp | |||||||||
Cerner Results
| ||||||||||
Actual Epic Build 3/11/2025
| PROCEDURE ID | 114108 | ||||||||||||||||||
| PDM | 5963016 | ||||||||||||||||||
| ORDER DISPLAY NAME | Infliximab Concentration and Infliximab Antibody | ||||||||||||||||||
| PROCEDURE NAME | INFLIXIMAB CONCENTRATION & AB | ||||||||||||||||||
| PROCEDURE MASTER NUMBER | LAB10792 | ||||||||||||||||||
| SHORT PROCEDURE NAME | INFLIXIMAB CONCENTRATION & AB | ||||||||||||||||||
| CATEGORY CODE | 1.0 | ||||||||||||||||||
| CATEGORY CODE RECORD NAME | LAB BLOOD ORDERABLES | ||||||||||||||||||
| SYNONYMS | REMICADE ANTI-TNF-ALPHA |
||||||||||||||||||
| CLINICALLY ACTIVE | Yes | ||||||||||||||||||
| ORDERABLE | Yes | ||||||||||||||||||
| PERFORMABLE | Yes | ||||||||||||||||||
| FILTER GENOMICS | |||||||||||||||||||
| REFERENCE LINK URL | https://labs.northwell.edu/epic/test/114108 | ||||||||||||||||||
| ORDERING INSTRUCTIONS | |||||||||||||||||||
| DEFAULT SPECIMEN TYPE | Blood | ||||||||||||||||||
| SPECIMEN TYPE PICK LIST | Blood | ||||||||||||||||||
| SPECIMEN TYPE LIST | |||||||||||||||||||
| OP SPECIMEN TYPE LIST | |||||||||||||||||||
| SPECIMEN SOURCE PICK LIST | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||||||||
| SPECIMEN SOURCE DEFAULT - MALE | Blood, Venous | ||||||||||||||||||
| SPECIMEN SOURCE DEFAULT - FEMALE | Blood, Venous | ||||||||||||||||||
| SPECIMEN SOURCE LIST | |||||||||||||||||||
| OP SPECIMEN SOURCE LIST | |||||||||||||||||||
| IP LAB TEST COMPONENTS FOR REPORT | INFLIXIMAD INFLIXAB |
||||||||||||||||||
| OP LAB TEST COMPONENTS FOR REPORT | INFLIXIMAD INFLIXAB |
||||||||||||||||||
| ORDER QUESTIONS | [] | ||||||||||||||||||
| ORDER QUESTIONS RECORD NAME | |||||||||||||||||||
| INPATIENT ORDER QUESTIONS | [] | ||||||||||||||||||
| INPATIENT ORDER QUESTIONS RECORD NAME | |||||||||||||||||||
| ORDER SPECIFIC QUESTION OVERRIDE | |||||||||||||||||||
| INPATIENT QUESTION OVERRIDE | |||||||||||||||||||
| LOCATION RESTRICT LIST IP | |||||||||||||||||||
| LOCATION RESTRICT LIST IP RECORD NAME | |||||||||||||||||||
| LOCATION RESTRICT LIST INCLUDE IP | |||||||||||||||||||
| LOCATION RESTRICT LIST OP | |||||||||||||||||||
| LOCATION RESTRICT LIST OP RECORD NAME | |||||||||||||||||||
| LOCATION RESTRICT LIST INCLUDES OP | |||||||||||||||||||
| EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME | |||||||||||||||||||
| EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME | |||||||||||||||||||
| EDP IP SPECIMEN SOURCE | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary |
||||||||||||||||||
| EDP OP SPECIMEN SOURCE | |||||||||||||||||||
| EDP IP SPECIMEN TYPE | Blood | ||||||||||||||||||
| EDP OP SPECIMEN TYPE | |||||||||||||||||||
| DERIVED EDP IP BUTTONS S | Blood, Central Line Blood, Arterial Blood, Capillary Blood, Venous |
||||||||||||||||||
| DERIVED EDP IP BUTTONS T | Blood | ||||||||||||||||||
| DERIVED EDP OP BUTTONS S | |||||||||||||||||||
| DERIVED EDP OP BUTTONS T | |||||||||||||||||||
| IP ORDERABLE | 1 | ||||||||||||||||||
| OP ORDERABLE | 1 | ||||||||||||||||||
| STANDARD LAB COMPONENTS | |||||||||||||||||||
| STANDARD LAB COMPONENTS RECORD NAME | |||||||||||||||||||
| COMPONENT DATA REQUIREMENT | |||||||||||||||||||
| EPIC OP AOEs | |||||||||||||||||||
| EPIC IP AOEs | |||||||||||||||||||
EPIC Components (results - crosswalked through Cerner)
| |||||||||||||||||||